The risk of recurrence in women with venous thromboembolism while using estrogens: A prospective cohort study

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 5, 2014, Pages 635-640

  Eischer, L ^a   Eichinger, S ^a,b   Kyrle, P A ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Karl Landsteiner Institute of Thrombosis Research   (Austria)

Author keywords

Estrogens; Hormone replacement therapy; Pulmonary embolism; Recurrence; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; ESTROGEN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG USE; DRUG WITHDRAWAL; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MIDDLE AGED; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM; AUSTRIA; ORAL DRUG ADMINISTRATION; PROBABILITY; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; AGED; ANTICOAGULANTS; AUSTRIA; ESTROGENS; FEMALE; HUMANS; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84901193243     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12528     Document Type: Article

References (12)

1. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR, American College of Chest Physicians. Antithrombotic therapy for venous thromboembolic disease. Chest 2012; 141: e419S-94S.
2. Kyrle PA, Minar E, Bialonczyk C, Hirschl M, Weltermann A, Eichinger S. The risk of recurrent venous thromboembolism in ten and women. N Engl J Med 2004; 350: 2558-63.
3. Douketis J, Tosetto A, Marcucci M, Baglin T, Cosmi B, Cushman M, Kyrle P, Poli D, Tait RC, Iorio A. Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis. BMJ 2011; 342: d813. doi:10.1136/bmj.d813.
4. Le Gal G, Kovacs MJ, Carrier M, Do K, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Lacut K, White RH, Vickars L, Rodger M. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study. Thromb Haemost 2010; 104: 498-503.
5. Le Moigne E, Delluc A, Tromeur C, Nowak E, Mottier D, Lacut K, Le Gal G. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study. Thromb Res 2013; 132: 51-5.
6. Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293: 2352-61.
7. Cushman M, Glynn RJ, Goldhaber SZ, Moll S, Bauer KA, Deitcher S, Shrivastava S, Ridker PM. Hormonal factors and risk of recurrent venous thrombosis: the prevention of recurrent venous thromboembolism trial. J Thromb Haemost 2006; 4: 2199-203.
8. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: The Vienna prediction model. Circulation 2010; 121: 1630-6.
9. Beyth RJ, Quinn L, Landefeld CS. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin. A randomized, controlled trial. Ann Intern Med 2000; 133: 687-95.
10. Vandenbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-7.
11. Eichinger S, Pabinger I, Stümpflen A, Hirschl M, Bialonczyk C, Schneider B, Melichart M, Rintelen C, Speiser W, Mannhalter C, Minar E, Lechner K, Kyrle PA. The risk of recurrent venous thromboembolism in patients without and with factor V Leiden. Thromb Haemost 1997; 77: 624-8.
12. Kyrle PA, Rosendaal FR, Eichinger S. Risk assessment for recurrent venous thrombosis. Lancet 2010; 376: 2031-9.